论文部分内容阅读
目的:探讨腺苷脱氨酶(ADA)、癌胚抗原(CEA)、CA125在肺结核患者中的临床应用价值。方法:2014年6月至2015年6月选取本院收治的80例肺结核患者为研究对象,另选取80例健康体检者为对照组,应用液体双试剂速率法测定两组ADA水平,应用ELISA法测定两组CEA、CA125水平。结果:肺结核组患者血清ADA、CEA、CA125水平均高于对照组(P<0.05)。结论:应用ADA、CEA、CA125能有效对肺结核患者作出诊断,具有较高的临床应用价值。
Objective: To investigate the clinical value of adenosine deaminase (ADA), carcinoembryonic antigen (CEA) and CA125 in patients with pulmonary tuberculosis. Methods: From June 2014 to June 2015, 80 patients with tuberculosis admitted to our hospital were enrolled in this study. Another 80 healthy people were selected as the control group. ADA level was measured by liquid double reagent rate method. Two groups of CEA, CA125 levels were measured. Results: The levels of ADA, CEA and CA125 in patients with pulmonary tuberculosis were significantly higher than those in control group (P <0.05). Conclusion: The application of ADA, CEA, CA125 can effectively diagnose patients with pulmonary tuberculosis, which has high clinical value.